Merck & Co. Statistics
Total Valuation
Merck & Co. has a market cap or net worth of BRL 1.17 trillion. The enterprise value is 1.31 trillion.
Market Cap | 1.17T |
Enterprise Value | 1.31T |
Important Dates
The next estimated earnings date is Tuesday, July 29, 2025.
Earnings Date | Jul 29, 2025 |
Ex-Dividend Date | Jun 13, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.30% |
Shares Change (QoQ) | -0.24% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 2.51B |
Valuation Ratios
The trailing PE ratio is 11.72 and the forward PE ratio is 9.38.
PE Ratio | 11.72 |
Forward PE | 9.38 |
PS Ratio | 3.20 |
PB Ratio | 4.22 |
P/TBV Ratio | 18.76 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.12, with an EV/FCF ratio of 13.45.
EV / Earnings | 13.15 |
EV / Sales | 3.70 |
EV / EBITDA | 8.12 |
EV / EBIT | 9.69 |
EV / FCF | 13.45 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.72.
Current Ratio | 1.41 |
Quick Ratio | 0.83 |
Debt / Equity | 0.72 |
Debt / EBITDA | 1.20 |
Debt / FCF | 2.04 |
Interest Coverage | 19.06 |
Financial Efficiency
Return on equity (ROE) is 39.29% and return on invested capital (ROIC) is 19.33%.
Return on Equity (ROE) | 39.29% |
Return on Assets (ROA) | 13.81% |
Return on Invested Capital (ROIC) | 19.33% |
Return on Capital Employed (ROCE) | 27.14% |
Revenue Per Employee | 4.95M |
Profits Per Employee | 1.35M |
Employee Count | 75,000 |
Asset Turnover | 0.58 |
Inventory Turnover | 2.31 |
Taxes
In the past 12 months, Merck & Co. has paid 15.58 billion in taxes.
Income Tax | 15.58B |
Effective Tax Rate | 13.48% |
Stock Price Statistics
The stock price has decreased by -31.99% in the last 52 weeks. The beta is 0.40, so Merck & Co.'s price volatility has been lower than the market average.
Beta (5Y) | 0.40 |
52-Week Price Change | -31.99% |
50-Day Moving Average | 55.25 |
200-Day Moving Average | 66.71 |
Relative Strength Index (RSI) | 62.83 |
Average Volume (20 Days) | 6,792 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 2.19 |
Income Statement
In the last 12 months, Merck & Co. had revenue of BRL 366.50 billion and earned 99.96 billion in profits. Earnings per share was 39.44.
Revenue | 366.50B |
Gross Profit | 282.46B |
Operating Income | 139.96B |
Pretax Income | 115.64B |
Net Income | 99.96B |
EBITDA | 165.10B |
EBIT | 139.96B |
Earnings Per Share (EPS) | 39.44 |
Balance Sheet
The company has 52.91 billion in cash and 199.78 billion in debt, giving a net cash position of -146.87 billion.
Cash & Cash Equivalents | 52.91B |
Total Debt | 199.78B |
Net Cash | -146.87B |
Net Cash Per Share | n/a |
Equity (Book Value) | 277.50B |
Book Value Per Share | 110.14 |
Working Capital | 59.22B |
Cash Flow
In the last 12 months, operating cash flow was 119.70 billion and capital expenditures -22.01 billion, giving a free cash flow of 97.69 billion.
Operating Cash Flow | 119.70B |
Capital Expenditures | -22.01B |
Free Cash Flow | 97.69B |
FCF Per Share | n/a |
Margins
Gross margin is 77.07%, with operating and profit margins of 38.19% and 27.27%.
Gross Margin | 77.07% |
Operating Margin | 38.19% |
Pretax Margin | 31.55% |
Profit Margin | 27.27% |
EBITDA Margin | 45.05% |
EBIT Margin | 38.19% |
FCF Margin | 26.66% |
Dividends & Yields
This stock pays an annual dividend of 1.57, which amounts to a dividend yield of 2.71%.
Dividend Per Share | 1.57 |
Dividend Yield | 2.71% |
Dividend Growth (YoY) | 19.42% |
Years of Dividend Growth | 2 |
Payout Ratio | 45.54% |
Buyback Yield | 0.30% |
Shareholder Yield | 3.01% |
Earnings Yield | 8.53% |
FCF Yield | 8.34% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on October 29, 2020. It was a forward split with a ratio of 8.
Last Split Date | Oct 29, 2020 |
Split Type | Forward |
Split Ratio | 8 |
Scores
Merck & Co. has an Altman Z-Score of 4.7 and a Piotroski F-Score of 7.
Altman Z-Score | 4.7 |
Piotroski F-Score | 7 |